Amphion Innovations plc is a principal investment firm specializing in both public and private early stage investments and spun out of universities and corporations. It does not invest in “speculative” technologies requiring long development timeframes or excessive capital investment. It invests in the medical, life sciences, and technology sectors with defensible core intellectual property, know-how and growth potential in very large markets of at least $1 billion in size together with corporations, governments, universities, and entrepreneurs. The firm typically invests in companies with broad-based, proprietary, platform technologies in the areas of pharmacogenomics, proteomics, nutriceut...
330 Madison Avenue
New York, NY 10017
Founded in 1984
Amphion Innovations Plc Announces Audited Consolidated and Company Earnings Results for the Year Ended December 31, 2014
Jun 23 15
Amphion Innovations Plc announced audited consolidated and company earnings results for the year ended December 31, 2014. For the year, on consolidated basis, the company announced revenue of $484,700 compared to $1,016,990 a year ago. Operating loss was $3,009,651 compared to $2,576,745 a year ago. Loss before tax was $12,589,279 compared to $6,385,416 a year ago. Loss was $12,589,703 or $0.09 per basic and diluted share compared to $6,382,194 or $0.04 per basic and diluted share a year ago. Net cash used in operating activities was $1,976,585 compared to $1,701,969 a year ago. Purchases of investments were $286,259 compared to $204,959 a year ago.
For the year, on company only basis, the company announced operating loss was $1,121,478 compared to $1,099,965 a year ago. Loss before tax was $10,880,335 compared to $4,927,980 a year ago. Loss was $10,880,335 compared to $4,927,980 a year ago. Net cash used in operating activities was $3,110,973 compared to $650,844 a year ago. Purchases of investments were $286,259 compared to $204,959 a year ago.
Amphion Innovations plc Reports Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2014
Sep 19 14
Amphion Innovations plc reported unaudited consolidated earnings results for the six months ended June 30, 2014. For the period, the company reported revenue was $240,000 compared to $264,638 a year ago. Operating loss was $1,769,275 compared to $1,025,023 a year ago. Loss before tax was $8,104,687 against $3,001,081 for the same period a year ago. Loss was $8,104,750 or $0.06 per basic and diluted share against $3,058,131 or $0.02 per basic and diluted share for the same period a year ago. Net cash used in operating activities was $2,428,337 against $1,090,317 for the same period a year ago. Net asset value per share at June 30, 2014 was $0.04.
Amphion Innovations plc Names Mr. Miroslaw Izienicki as Non-Executive Director
Aug 28 14
Amphion Innovations plc announced the appointment of Mr. Miroslaw Izienicki as non-executive director with immediate effect. Mr. Izienicki, age 57, is a career banker with experience of providing high level corporate finance advisory and M&A services, particularly in respect of multi-stakeholder engagements at or near the interface of government and commerce. Mr. Izienicki, after having served as Chief Operating Officer, is currently Senior Adviser to Gamma Finance LLP. Previously, he was Managing Director of Fifth Capital Group.